What’s the current market cap for Stevanato Group stock?

Stevanato Group (STVN) has a market cap of $4.9B as of May 23, 2026.

What is the P/E ratio for Stevanato Group stock?

The price to earnings (P/E) ratio for Stevanato Group (STVN) stock is 30.43 as of May 23, 2026.

Does Stevanato Group stock pay dividends?

Yes, the Stevanato Group (STVN) stock pays dividends to shareholders. As of May 23, 2026, the dividend rate is $0.06263 and the yield is 0.35%. Stevanato Group has a payout ratio of 10.42% on a trailing twelve-month basis.

When is the next Stevanato Group dividend payment date?

The next Stevanato Group (STVN) dividend payment date is unconfirmed.

What is the beta indicator for Stevanato Group?

Stevanato Group (STVN) has a beta rating of 0.75. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy Stevanato Group stock | $STVN Share Price

About Stevanato Group

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Ticker

$STVN

Sector

Health

Primary listing

NYSE

Employees

6,010

Headquarters

Piombino Dese, Italy

Website

www.stevanatogroup.com

Stevanato Group Metrics

BasicAdvanced

$4.9bn

30.43

$0.59

0.75

$0.06

0.35%

What the Analysts think about Stevanato Group

Analyst ratings (Buy, Hold, Sell) for Stevanato Group stock.

Stevanato Group Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

Stevanato Group Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Stevanato Group News

AllArticlesVideos

Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026

Business Wire·2 weeks ago

Stevanato Group to Participate in Three Upcoming Investor Conferences

Business Wire·3 weeks ago

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

Business Wire·2 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.